Sprout Pharmaceuticals Inc.

Canadian pharmaceutical behemoth Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced on Thursday that it would be acquiring Sprout Pharmaceuticals Inc., the maker of female libido drug Addyi for $1 billion. On Tuesday, Addyi received FDA's approval, becoming the first female libido drug...